CuraTeQ Biologics
- Biotech or pharma, therapeutic R&D
- CMO, CRO
๐๐๐ฟ๐ฎ๐ง๐ฒ๐ค ๐๐ถ๐ผ๐น๐ผ๐ด๐ถ๐ฐ๐ (an Aurobindo Pharma company) is an ๐๐จ ๐๐ ๐ฃ ๐ฐ๐ฒ๐ฟ๐๐ถ๐ณ๐ถ๐ฒ๐ฑ biopharmaceutical company based in Hyderabad, India.
CuraTeQ has a development pipeline of 14 biosimilars. Three products have been filed with EMA, one product with MHRA, and four products are in global PhIII clinical trials.
- ๐๐ฒ๐๐พ๐ผ๐น๐๐ฎยฎ (Bevacizumab biosimilar) has received MHRA approval.
- ๐๐๐ฟ๐๐ฝ๐ฒ๐ดยฎ (Pegfilgrastim biosimilar) has received EMA approval.
- ๐ญ๐ฒ๐ณ๐๐น๐๐ถยฎ (Filgrastim biosimilar) has received EMA approval.
- ๐๐ฎ๐๐๐ฏ๐น๐๐ยฎ (Trastuzumab biosimilar) has received CHMP positive opinion, and CDSCO approval in India.
๐ข๐๐ฟ ๐๐ณ๐ณ๐ถ๐น๐ถ๐ฎ๐๐ฒ๐ ๐ฎ๐ป๐ฑ ๐ฆ๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ ๐ผ๐ณ๐ณ๐ฒ๐ฟ๐ถ๐ป๐ด๐:
- ๐๐๐ฟ๐ผ ๐ฃ๐ฒ๐ฝ๐๐ถ๐ฑ๐ฒ๐, our synthetic peptide API manufacturing arm, has filed 14 DMFs with US FDA contributing to 6 ANDA approvals and 2 CEP approvals.
- ๐๐๐ ๐ข ๐ฆ๐ฒ๐ฟ๐๐ถ๐ฐ๐ฒ๐: we offer wide range of CDMO services across biologics, peptides, vaccines and oligonucleotides.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}